Nobel Prize–winning biologist Randy Schekman lauds Bengaluru’s leadership in biological research, urges more support for institutions like NCBS, and highlights breakthroughs in genome editing and ...
If you are wondering whether CRISPR Therapeutics at about US$53.84 is still priced attractively or already baking in a lot of expectations, you are asking the right question. The stock has seen a ...
Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...
Venkatesan Sundaresan and Imtiyaz Khanday have already moved on to maize, millets. ‘What works with rice is potentially ...
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
A notable surge in investment activity has emerged around Intellia Therapeutics, with significant share acquisitions by both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback